Sorted By:

Relevance


O365 Senior Manager – Information Technology

PhRMA  |  PhRMA Career

We are committed to supporting our family of professionals at PhRMA and strive to create programs that help our team members manage the challenges of balancing a fast-paced career with their own personal goals.
https://www.phrma.org

Real world evidence: Not just “big data”

PhRMA  |  Blog Post

Hubbard leverages his policy and technology experience to examine ways the country's health care system can be transformed, focusing on the promotion of medical innovation and the improvement of quality and efficiency in clinical care.
http://catalyst.phrma.org/real-world-evidence-not-just-big-data

PhRMA Statement on NAFTA Tribunal Decision in the Eli Lilly Case

PhRMA  |  Press Release

“If Canada truly plans to recognize the importance of innovation, and evolve from a natural-resource based economy to one founded on science, innovation, and research, either the Courts or Parliament must fix this backwards policy.
https://www.phrma.org

Jacob B.

From Hope To Cures  |  From Our Network

Thanks to an incredible partnership between our hospital and Nike, Jacob is one of six patients out of hundreds of thousands that were given the opportunity to design a one-of-a-kind pair of shoes & apparel that will benefit the hospital that saves children’s lives on a daily basis.
http://www.fromhopetocures.org/imnotaverage/jacob-b

Senior Director – Science and Regulatory Advocacy (Biologics and Biosimilars Advocacy)

PhRMA  |  PhRMA Career

We are committed to supporting our family of professionals at PhRMA and strive to create programs that help our team members manage the challenges of balancing a fast-paced career with their own personal goals.
https://www.phrma.org/careers/senior-director-science-and-regulatory-advocacy-biologics-and-biosimilars-advocacy1

PhRMA Statement on Flawed British Medical Journal Analysis

PhRMA  |  Press Release

“Ultimately, to help ensure that the U.S. remains the world leader in medical innovation, a consistent pro-innovation policy framework must be in place that provides regulatory certainty, ensures patient choice and access to medicines and incentivizes future research and development.”
https://www.phrma.org/press-release/phrma-statement-on-flawed-british-medical-journal-analysis

Physicians Deserve Timely Authoritative Risk Information For Medicines

PhRMA  |  Blog Post

We support the FDA’s efforts to provide clear direction regarding best practices for disseminating peer-reviewed articles and information to physicians and other professionals.
http://catalyst.phrma.org/physicians-deserve-timely-authoritative-risk-information-for-medicines

Senior Manager – Human Resources

PhRMA  |  PhRMA Career

Please check our careers page for more opportunities. 
https://www.phrma.org/careers/senior-manager-human-resources

U.S. is Still Most Attractive Country for Biopharma Investment; BRICs, Canada Lag Behind

PhRMA  |  Press Release

Nevertheless, in markets that have taken major steps to improve elements of the policy environment – such as Singapore and Israel, which have made significant strides in IP and regulatory standards in recent years – executives display much greater confidence, with these economies averaging at least 75% of the total possible BCI score.”
https://www.phrma.org/press-release/u-s-is-still-most-attractive-country-for-biopharma-investment-brics-canada-lag-behind

PhRMA Careers, Senior Director of Accounting

PhRMA  |  PhRMA Career

We are committed to supporting our staff and strive to create programs that help our team manage the challenges of balancing a fast paced career with personal goals.
https://www.phrma.org/careers/phrma-careers-senior-director-of-accounting

Week in Review: The Latest from PhRMA

PhRMA  |  Blog Post

Learn more about how patients and payers are impacted.
http://catalyst.phrma.org/week-in-review-the-latest-from-phrma-september-25-2015

Rodger Currie

PhRMA  |  Biography

A lawyer, Currie was an associate at the healthcare law firm of Fox, Bennett, and Turner prior to working on Capitol Hill and later worked as a partner to legendary healthcare advocate Nick Littlefield at the law firm of Foley Hoag.
https://www.phrma.org/biography/rodger-currie

Joint BIO/PhRMA Statement on PDUFA Reauthorization

PhRMA  |  Press Release

., and Biotechnology Industry Organization (BIO) Senior Vice President of Science Policy Kay Holcombe released the following joint statement on the reauthorization of the Prescription Drug User Fee Act (PDUFA): “For more than 20 years, PDUFA has helped the Food and Drug Administration (FDA) fulfill its central mission of protecting and promoting public health by allowing the Agency to keep pace with the rapid increase in the number and complexity of innovative drugs and biologics requiring regulatory review.
https://www.phrma.org/press-release/joint-bio/phrma-statement-on-pdufa-reauthorization

Responsible Clinical Trial Data Sharing Is Enhancing Science and Improving Patient Health

PhRMA  |  Blog Post

Just a few examples of the industry’s data sharing programs include: Pfizer created a comprehensive data access policy and web portal to facilitate researchers, trial participants, regulators, and others acting in the best interest of patients to have access to clinical trial information to advance medical understanding and progress.
http://catalyst.phrma.org/responsible-clinical-trial-data-sharing-is-enhancing-science-and-improving-patient-health

Enforcing unmet trade obligations protects U.S. innovation

PhRMA  |  Blog Post

Trade agreements, such as the WTO TRIPS agreement, ensure proper RDP periods and bar disclosure and unfair commercial use of an innovator’s test data.
http://catalyst.phrma.org/enforcing-unmet-trade-obligations-protects-us-innovation

Poll respondents appreciate economic benefits of innovation and call for more protections

PhRMA  |  Blog Post

Two-thirds would like the U.S. to do more to prevent other countries from using inventions without proper compensation, and 68 percent want more on preventing other countries from infringing on trade deals that put inventions at risk from being stolen.
http://catalyst.phrma.org/poll-respondents-appreciate-economic-benefits-of-innovation-and-call-for-more-protections

India—Seizing the Opportunity

PhRMA  |  Blog Post

I am eager to work here and bring colleagues along so that we can make India’s dream of being a global player in the innovative pharmaceutical sector a reality.
http://catalyst.phrma.org/india-seizing-the-opportunity

Senior Director - Public Affairs Research

PhRMA  |  PhRMA Career

We are committed to supporting our family of professionals at PhRMA and strive to create programs that help our team members manage the challenges of balancing a fast-paced career with their own personal goals.
https://www.phrma.org/careers/senior-director-public-affairs-research

Medicare Monday: A guide to MedPAC’s Part D vote this week

PhRMA  |  Blog Post

Keep an eye on MedPAC activity later this week to see what happens with these draft recommendations.
http://catalyst.phrma.org/medicare-monday-a-guide-to-medpacs-part-d-vote-this-week

Finding cures for incurable diseases

PhRMA  |  Blog Post

Our regulatory system must keep pace with the science and embrace the latest tools to improve the process to deliver these treatments to patients.
http://catalyst.phrma.org/finding-cures-for-incurable-diseases

Senior Director - Science and Regulatory Advocacy (Drug Development Tools)

PhRMA  |  PhRMA Career

We are committed to supporting our family of professionals at PhRMA and strive to create programs that help our team members manage the challenges of balancing a fast-paced career with their own personal goals.
https://www.phrma.org/careers/senior-director-science-and-regulatory-advocacy

Sharing Negotiated Discounts Could Save Patients More than $800 Annually and Would Increase Premiums About 1 Percent

PhRMA  |  Press Release

He would save $204 per month until he meets his deductible and then $41 per month until he reaches his out-out-pocket maximum, allowing him to spread his costs throughout the year.
https://www.phrma.org/press-release/sharing-negotiated-discounts-could-save-patients-more-than-800-annually-and-would-increase-premiums-about-1-percent

PhRMA Foundation Awards Comparative Effectiveness Grants

PhRMA  |  Press Release

By funding the research of more than 2,200 young scientists, the Foundation has helped pave the way for the future of biopharmaceutical care.  
https://www.phrma.org/press-release/phrma-foundation-awards-comparative-effectiveness-grants

New Data Show More Than Half of Patients’ Out-of-Pocket Spending for Brand Medicines Is Based on List Price

PhRMA  |  Press Release

“In many respects, our current marketplace for medicines works for patients, but we need to ensure patients receive more of the benefit of price negotiations between biopharmaceutical companies and payers,” said Ubl.
https://www.phrma.org/press-release/new-data-show-more-than-half-of-patients-out-of-pocket-spending-for-brand-medicines-is-based-on-list-price

Share the Savings

PhRMA  |  From PhRMA

According to a recent study from the Berkeley Research Group, more than a third of the list price for brand medicines is rebated back to payers and the supply chain.
https://www.phrma.org/discounts

You have reviewed the first 375 results out of 1100. Each page contains 25 results. You're on page 15.

prev 13 14 15 16 17 18 next